Spero Therapeutics, Inc.
SPRO$160M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBRIDGE32 employees
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
7wMarket Overview
Stock performance and key metrics
SPRO News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
TBP-PI-HBr
Urinary Tract Infection
TBPM-PI-HBr
Complicated Urinary Tract Infection
SPR720 500 mg
Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TBP-PI-HBr | Phase 3 | Urinary Tract Infection | - | - |
TBPM-PI-HBr | Phase 3 | Complicated Urinary Tract Infection | - | - |
SPR720 500 mg | Phase 2 | Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply